Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022

Yasmeen Rahimi Downgraded (ALGS) to Hold and Decreased Target to $100 on, Mar 23rd, 2022

Yasmeen Rahimi of Piper Sandler, Downgraded "Aligos Therapeutics, Inc." (ALGS) to Hold and Decreased Target from $375 to $100 on, Mar 23rd, 2022.

Yasmeen has made no other calls on ALGS in the last 4 months.



There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $300 on, Friday, January 7th, 2022